Laws
Treaties
Judgments
Browse By Jurisdiction
Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301 et seq., United States of America
Back
Superseded Text
Go to latest Version in WIPO Lex
Year of Version
2004
Dates
Amended up to:
January 6, 2020
Type of Text
IP-related Laws
Subject Matter
Patents (Inventions),
Competition,
Undisclosed Information (Trade Secrets),
Enforcement of IP and Related Laws,
Transfer of Technology
Notes
Originally passed by Congress in 1938, the FD&C Act is a set of laws giving authority to the U.S. Food and Drug Administration (FDA) to oversee the safety and efficacy of food, drugs, and cosmetics. Since then, the FD&C Act has been amended numerous times, including by the Drug Price Competition and Patent Term Restoration Act (a.k.a. the Hatch-Waxman Act) of 1984. This federal law set forth a process by which producers of generic drugs can file Abbreviated New Drug Applications (ANDAs) to seek FDA approval before the patent protection period has expired for the branded counterpart (see Chapter V, Subchapter A - ‘New Drugs,’ section 505(j) (21 U.S.C. 355(j)). Also, first-to-file ANDA holders are granted 180 days of generic exclusivity (see Chapter V, Subchapter A - ‘New Drugs,’ section 505(j)(5)(B)(iv)).
Please note that section 505 appears in the U.S. Code as section number 21 U.S.C 355.
Implementing regulations can be found in the Code of Federal Regulations Title 21.
Available Texts
Main text(s)
Main text(s)
English
Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301 et seq.
PDF
HTML
Legislation
Is amended by (1 text(s))
Is amended by (1 text(s))
Is implemented by (1 text(s))
Is implemented by (1 text(s))
Is superseded by (1 text(s))
Is superseded by (1 text(s))
WIPO Lex No.
US200